Cargando…
HapMap‐based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non‐smokers
BACKGROUND: The aim of this study was to evaluate the association between CYP2A13 polymorphisms and lung cancer susceptibility using the HapMap database. METHODS: A case‐control analysis of 532 subjects with lung cancer and 614 controls with no personal history of the disease was performed. The tag...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449263/ https://www.ncbi.nlm.nih.gov/pubmed/30807688 http://dx.doi.org/10.1111/1759-7714.12954 |